Chronic kidney disease is a common and often progressive condition that raises the risk of heart disease, disability and early death.
New research suggests that weight‑loss surgery or bariatric surgery, already used to treat severe obesity, may also substantially improve long‑term outcomes for people living with both obesity and kidney disease.
The findings were presented in May at the annual meeting of the American Society for Metabolic and Bariatric Surgery and draw on real‑world health records from thousands of patients.
Understanding basic
Chronic kidney disease, or CKD, occurs when the kidneys gradually lose their ability to filter waste and excess fluid from the blood. In its later stages, people may need dialysis or a kidney transplant to survive.
Obesity is a major risk factor for CKD, alongside diabetes and high blood pressure. Excess body fat can worsen insulin resistance, raise blood pressure and trigger inflammation, all of which strain the kidneys and blood vessels. People with obesity and CKD also face a high risk of heart attack and stroke.
Metabolic and bariatric surgery includes procedures such as sleeve gastrectomy and Roux‑en‑Y gastric bypass. These operations reduce stomach size and alter gut hormones, leading to sustained weight loss and improvements in blood sugar and blood pressure.
What the new evidence shows
The study analysed electronic health records from more than 8,900 adults with obesity and CKD in the United States between 2010 and 2020. Researchers compared five‑year outcomes for patients who had bariatric surgery with similar patients who did not.
People who underwent surgery had markedly better outcomes. About 6 per cent progressed to end‑stage kidney disease, compared with nearly 12 per cent in the non‑surgical group. They were also less likely to need dialysis and more than twice as likely to receive a kidney transplant.
Heart attacks and strokes were far less common among surgery patients, and deaths from any cause were substantially lower over the five‑year follow‑up.
In simple terms, patients who had surgery appeared to live longer and experience fewer serious complications.
How surgery might help the kidneys and heart
Weight‑loss surgery does more than reduce body weight. It often leads to rapid and lasting improvements in blood sugar control, blood pressure and cholesterol levels.
Lower blood pressure reduces strain on the small blood vessels in the kidneys. Better control of diabetes limits damage to kidney filters and blood vessels. Surgery also appears to reduce chronic inflammation and improve how the body handles insulin, both of which are linked to slower kidney decline and better heart health.
Together, these changes may help slow CKD progression and lower the risk of cardiovascular disease, which is the leading cause of death in people with kidney disease.
How strong is the evidence?
The study is based on observational data rather than a randomised clinical trial. This means it can show strong associations but cannot prove that surgery alone caused the better outcomes.
Researchers attempted to match surgical and non‑surgical patients with similar health profiles, but unmeasured differences may still exist. People who are well enough and able to access surgery may differ in important ways from those who do not.
Even so, the large sample size and consistent results across multiple outcomes strengthen the findings and align with earlier research showing kidney and heart benefits after bariatric surgery.
What this means for patients
For people with obesity and CKD, the results suggest that bariatric surgery may offer benefits beyond weight loss, potentially slowing kidney damage and reducing the risk of life‑threatening complications.
This does not mean surgery is suitable or necessary for everyone with kidney disease. Bariatric procedures carry risks and require lifelong medical follow‑up, nutritional monitoring and lifestyle changes.
Decisions about surgery should be made with specialist teams, taking into account kidney function, overall health and personal circumstances. Always talk to your healthcare providers before deciding on any medical intervention.
Implications for treatment and care
Current CKD management focuses on controlling blood pressure, blood sugar and cardiovascular risk. These findings suggest that metabolic surgery may deserve consideration earlier in the disease course for selected patients with severe obesity.
In some cases, weight‑loss surgery may also improve eligibility for kidney transplantation by reducing surgical risk and improving overall health.
However, access to bariatric surgery varies widely, and insurance coverage and referral practices differ between health systems.
Nuanced perspectives
More research is needed to determine which patients benefit most, the optimal timing of surgery and whether similar results would be seen outside the United States.
Randomised trials would help clarify cause and effect, though these are difficult to conduct for surgical treatments. Long‑term studies are also needed to assess outcomes beyond five years.
Chronic kidney disease affects millions of people worldwide and places a heavy burden on health systems. This study adds to growing evidence that treating obesity more aggressively can influence the course of other chronic diseases.
Rather than focusing solely on weight, metabolic surgery may offer a way to improve kidney and heart health together. For now, it highlights the importance of addressing obesity as part of comprehensive care for people with chronic kidney disease.
The post Weight‑Loss Surgery Cuts Risk of Kidney Failure, Heart Attack and Death in People with Obesity and Chronic Kidney Disease first appeared on PP Health Malaysia.
